CN105349474A
|
|
Lactobacillus.crispatus for preventing female urogenital tract infection
|
CN105211497A
|
|
A kind of compound probiotic novel fodder additive and application thereof
|
CN105194668A
|
|
Method for preparing conjugate of gp96 protein and PD1 antibody, and application of conjugate
|
CN105273064A
|
|
Double-target anti-HIV (anti-human immunodeficiency virus) glycopeptide compound and application thereof
|
CN105176849A
|
|
Preparation method and application of Trichoderma reesei strain capable of highly yielding penicillium janczewskii Zaleski alpha-galactosidase
|
CN105176899A
|
|
Method for constructing recombinant strain capable of producing target gene product at high yield, and recombinant strain and application thereof
|
CN105177110A
|
|
Detection method of nucleic acid
|
CN105132349A
|
|
Recombinant cell screening system and building method thereof
|
CN105144903A
|
|
Potato land preparation method and application thereof to potato cultivation
|
CN105075637A
|
|
Potato cultivation method
|
CN105112298A
|
|
Trichoderma voglmayrii producing mycelium cultivation medium, method for preparing same and application
|
CN105062898A
|
|
Paecilomyces hepiali producing coremia on silkworm pupae and culture method thereof
|
CN105130932A
|
|
Compounds and uses of compounds in preparation of PTP1B inhibitors and drugs for treatment and/or prevention of diabetes type II
|
CN105056223A
|
|
Combined vaccine for inhibiting and / or preventing type A streptococcal infection
|
CN105062939A
|
|
Recombinant strain, construction method thereof, and method for improving yield of abamectin
|
CN105037479A
|
|
Antimicrobial compound based on fungus transformation, and preparation method and application thereof
|
CN104887694A
|
|
Antisense oligonucleotides targeting non-coding RNAs and application thereof in preparation of anti-influenza virus medicament
|
CN104988139A
|
|
Method for cultivating cotton resisting verticillium dahliae
|
CN105039168A
|
|
Trichoderma citrinoviride and application thereof
|
CN104758934A
|
|
Pharmaceutical composition for synergistic inhibition virus induced cell transformation and leukemia and application of pharmaceutical composition
|